NeuroSense Therapeutics Ltd

NASDAQ:NRSN   3:59:57 PM EDT
2.72
+0.17 (+6.67%)
4:08:24 PM EDT: $2.67 -0.05 (-1.84%)
Earnings Announcements

NeuroSense Announces First Quarter 2022 Financial Results

Published: 05/31/2022 12:37 GMT
NeuroSense Therapeutics Ltd (NRSN) - Neurosense Announces First Quarter 2022 Financial Results and Provides Business Update.
Neurosense Therapeutics Ltd - As of March 31, 2022, Neurosense Had Cash and Short-term Deposits in a Total Amount of $13.74 Million.
Neurosense Therapeutics Ltd - Qtrly Basic and Diluted Net Loss per Share $0.24.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.